Drug Research

An international team of researchers - led by scientists at UC San Francisco, Stanford University, the University of North Carolina (UNC), and the Friedrich-Alexander University Erlangen-Nürnberg in Germany has developed a new opioid drug candidate that...

ViiV Healthcare announced the start of a phase III programme to support regulatory filings for a two-drug regimen of dolutegravir (Tivicay®) and lamivudine (Epivir®) as a treatment for HIV-1 infection in adults who have not received prior antiretroviral therapy....

The two most popular injectables used to transition are disappearing from shelves as one awaits re-approval by the FDA, but other factors remain murky The voice on the other the end of the phone had an...

Lupin Ltd, India’s third largest drug maker, will buy a portfolio of 21 generic brands from Osaka-based Shionogi & Co. Ltd at the cost of US $150 million. August 3, 2016: The move will help the company to strengthen. ...

Pfizer is the latest addition to an expanding list of drug makers found deviating from good manufacturing practices in India.In the last week of June,a high profile team drawn from world's four leading regulators identified a number of deficiencies...

A new set of community-produced biological network models has been shown to allow a deeper understanding of the mechanisms underlying a range of diseases. The models, of which earlier versions have been described in detail in...

Researchers at the Johns Hopkins Kimmel Cancer Center say they have developed a system that uses transformed human stem cells to speed up screening of existing drugs that might work against rare brain and other cancers. ...